Document is current
Any future updates will be listed below
-
Authors
Yong, Jiaxi https://orcid.org/0000-0001-7395-3425
Xu, Wang https://orcid.org/0009-0000-4129-4322
Wu, Miaomiao https://orcid.org/0000-0002-6572-6721
Zhang, Run https://orcid.org/0000-0002-0943-824X
Mann, Christopher W. G. https://orcid.org/0000-0001-8431-6317
Liu, Guoquan https://orcid.org/0000-0001-5979-785X
Brosnan, Christopher A. https://orcid.org/0000-0002-6589-985X
Mitter, Neena https://orcid.org/0000-0001-6146-6179
Carroll, Bernard J. https://orcid.org/0000-0002-1976-8269
Xu, Zhi Ping https://orcid.org/0000-0001-6070-5035
-
Funding
Funding for this research was provided by:
Department of Education and Training | Australian Research Council (DP190103486, IH190100022, IH190100022, DP190103486, IH190100022)
Department of Health | National Health and Medical Research Council (App1175808)
- License Information
-
More Information
Article History
Received: 30 October 2023
Accepted: 26 November 2024
First Online: 2 January 2025
Competing interests
: N.M., B.J.C. and Z.P.X. have received research grant funding from industry partners, which involves commercialization activities related to the LDH nanoparticles. Z.P.X., B.J.C., N.M., J.Y. and W.X. are inventors on an international patent filed by UniQuest that describes protein-coated LDH nanoparticles for nucleic acid delivery into plants (PCT/AU2024/050554). The other authors declare no competing interests.
